Glucosamine Market Report Scope & Overview:

The Glucosamine Market was valued at USD 1.01 Billion in 2025 and is expected to reach USD 1.69 Billion by 2035, growing at a CAGR of 5.30% from 2026 to 2035.

Glucosamine market is experiencing tremendous growth due to the rising demand for joint health supplements, usage in animal feed, as well as applications in skin care and cosmeceuticals. Glucosamine is an amino sugar that is produced naturally in the human body cartilage and widely used as a dietary supplement to relieve pain associated with osteoarthritis and promote joint health, considering the global prevalence of osteoarthritis disease along with the increased population of obese people. In addition, the growth in the market is being driven by increasing concern about joint health issues among aging populations, popularity of natural supplements over medicines, as well as increased investment and research and development activities in advanced microbial fermentation technologies to produce vegan glucosamine.

The global population aged 60 and above is expected to grow from 1.1 billion in 2023 to 1.4 billion by 2030, creating a large, aging patient base requiring long-term joint health symptom management that continues to directly sustain demand for glucosamine-based therapies and supplements across both pharmaceutical and nutraceutical distribution channels worldwide.

To Get More Information On Glucosamine Market - Request Free Sample Report

Glucosamine Market Trends

• Rising investment in fermentation-based glucosamine production is driving a technological shift toward more sustainable, non-shellfish-derived variants appealing to environmentally conscious and allergen-sensitive consumers.
• Growing consumer preference for convenient, pre-measured dosing formats is expanding capsule and tablet segment adoption, particularly among aging populations seeking simple, consistent supplementation routines.
• Increasing integration of glucosamine into functional foods and fortified products is expanding the ingredient's reach beyond traditional standalone joint health supplements into mainstream packaged food categories.
• Expanding retail pharmacy and online pharmacy distribution channels are improving glucosamine product accessibility, with online pharmacies showing particularly strong growth as consumers increasingly comfortable purchasing supplements digitally.
• Strategic partnerships among glucosamine producers, nutraceutical brands, and cosmeceutical companies are supporting development of increasingly diverse, application-specific glucosamine product portfolios.

The U.S. Glucosamine Market Outlook

The U.S. glucosamine market was valued at USD 0.33 Billion in 2025 and is projected to reach USD 0.56 Billion by 2035, growing at a CAGR of 5.30% during 2026–2035.

The major manufacturers of dietary supplements and nutraceuticals in the country have been expanding their glucosamine product lines owing to the rise in the geriatric population, the rising interest in preventive healthcare on the part of consumers, and the increasing use of dietary supplements. Further R&D efforts by the companies coupled with their innovative glucosamine products have strengthened the demand for glucosamine from shells and fermentation in the dietary supplement, pharmaceutical, and functional foods industries of the country.

In the international glucosamine market, North America held the highest revenue share of 38.85% in 2025, owing to robust domestic consumption of joint health products driven by an aging population base and the presence of an established retail distribution network for dietary supplements in the country.

Glucosamine Market Segment Analysis

• By Type, glucosamine sulfate dominated the glucosamine market with a 60.95% share in 2025, while glucosamine HCl is the fastest-growing type segment with a CAGR of 8.79% from 2026–2035.
• By Source, shellfish-derived dominated the glucosamine market with a 79.10% share in 2025, while fermentation-derived/vegan is the fastest-growing source segment with a CAGR of 7.74% from 2026–2035.
• By Application, nutritional supplements dominated the glucosamine market with a 79.95% share in 2025, while functional foods & fortified products is the fastest-growing application segment with a CAGR of 7.25% from 2026–2035.
• By Dosage Form, capsules dominated the glucosamine market with a 38.00% share in 2025, while liquid is the fastest-growing dosage form segment with a CAGR of 8.20% from 2026–2035.

By Type, glucosamine sulfate dominated the glucosamine market, while glucosamine HCl is the fastest-growing segment.

Based on product type, the percentage market share of glucosamine sulfate was 60.95% of the glucosamine market in 2025 due to the presence of significant clinical studies and its status as pharmaceutical grade. The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases has recommended that the pharmaceutical-grade glucosamine sulfate can be used alone and should not be combined with chondroitin.

Glucosamine HCl exhibits the highest growth rate at 8.79% CAGR through the forecast period, due to its stability benefits and lower production costs. The competition in the market among different types of glucosamine supplements is due to consumer demand and production efficiency because most producers are now opting for the HCl type that provides better shelf life and cheaper large-scale production than the sulfate type.

By Source, shellfish-derived dominated the glucosamine market, while fermentation-derived/vegan is the fastest-growing segment.

By source, shellfish-derived glucosamine commanded 79.10% share in 2025. Shellfish-derived glucosamine remains the dominant source category owing to its established, cost-effective extraction infrastructure from crustacean shells, representing the traditional and most widely available glucosamine sourcing method across the majority of global dietary supplement and pharmaceutical manufacturing.

Fermentation-derived variants are forecast to grow 7.74% annually through the forecast period. Aggressive capital investment and extensive research and development initiatives are currently heavily focused on scaling advanced microbial fermentation processes to yield high-purity, non-allergenic vegan glucosamine variants, appealing to environmentally conscious consumers and shellfish-allergic populations while aligning with stricter environmental regulations across key markets.

By Application, nutritional supplements dominated the glucosamine market, while functional foods & fortified products is the fastest-growing segment.

On account of its usage, nutritional supplements held a market share of 79.95% in the glucosamine market in 2025. The application segment that is Nutritional Supplements holds dominance in the market because of the positioning of glucosamine as a standalone supplement for joints, which is the primary usage by consumers across capsules, tablets, and powder forms.

Functional foods and fortified products record the quickest growth at 7.25% CAGR to the forecast period. Growing consumer interest in incorporating joint health benefits into everyday food and beverage products, rather than relying solely on standalone supplements, is driving rising segment growth as manufacturers increasingly fortify mainstream products with glucosamine to appeal to health-conscious consumers.

By Dosage Form, capsules dominated the glucosamine market, while liquid is the fastest-growing segment.

The capsules segment is predicted to dominate the market by having a market share of about 38.00% due to the growing preference for convenience dosing among consumers. The capsules segment has proved to be popular among aging consumers who want a straightforward supplementation regimen without having to deal with the taste and texture of liquid or powdered forms.

The Liquid segment is expected to witness the fastest CAGR of 8.20% during the forecast period 2026-2035. Growing consumer demand for glucosamine formats offering faster absorption and easier consumption, particularly among elderly consumers who may have difficulty swallowing capsules or tablets, is driving rising adoption of liquid glucosamine supplement formulations.

Regional Analysis

North America Glucosamine Market Insights

North America dominated the market with 38.85% share in revenue in 2025, owing to the high demand for joint supplements from the domestic market backed by the presence of the aging population along with robust dietary supplement retailing infrastructure in the region.

The United States is the dominant country within the North America glucosamine market in 2025 owing to the increasing geriatric population, consumer inclination towards preventive healthcare and consumption of dietary supplements. Canada is making contribution to the regional growth in terms of its growing natural health products market.

Get Customized Report as Per Your Business Requirement - Enquiry Now

Europe Glucosamine Market Insights

The Europe glucosamine market was a major contributor in 2025. This is attributed to the region's strong pharmaceutical-grade glucosamine sulfate market, supported by clinical endorsement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, alongside growing fermentation-based sustainable production investment.

Germany is one of the major markets in Europe owing to its strong pharmaceutical manufacturing base and growing consumer demand for clinically validated joint health supplements. Other countries such as France, where Rousselot has invested heavily in fermentation-based glucosamine production, and the United Kingdom are also contributing to market growth through expanding sustainable sourcing investment.

Asia Pacific Glucosamine Market Insights

Asia-Pacific is projected to post the highest regional CAGR of 7.99% during the forecast period. The market growth is driven by rising disposable incomes, growing consumer health consciousness, and expanding dietary supplement manufacturing capacity across the region's rapidly aging population.

China is one of the main growth drivers in the Asia Pacific glucosamine market, owing to its massive shellfish processing industry supporting glucosamine extraction and rapidly growing domestic dietary supplement consumption. Japan, South Korea, and India are also contributing to regional growth through expanding aging populations and growing consumer awareness of joint health supplementation benefits.

Middle East & Africa and Latin America Glucosamine Market Insights

Middle East & Africa and Latin American regions are gradually expanding glucosamine adoption as dietary supplement retail infrastructure develops and consumer awareness of joint health benefits grows across both regions.

Brazil is set to be a prominent Latin American market fueled by growing dietary supplement consumption and rising consumer interest in preventive healthcare products. The Middle East & Africa region has UAE and Saudi Arabia investing in modern retail infrastructure that is expanding access to premium joint health and nutraceutical product categories, including glucosamine-based offerings.

Market Dynamics

Growth Drivers: Rising joint health awareness and aging population demand driving market growth

The expanding demand for joint-health supplements, increasing use in animal nutrition, and new applications in skin care and cosmeceuticals are among the primary drivers of the glucosamine market. Increasing joint health concerns among aging populations and the popularity of natural supplements over pharmaceutical alternatives continue to serve as key growth enablers, with glucosamine's effectiveness alleviating joint pain making it particularly appealing to the elderly demographic and contributing to widespread utilization.

The growing prevalence of arthritis worldwide, combined with the increasing number of obese individuals, continues to set the stage for greater demand of this product in the foreseeable future. Rising awareness of health and wellness, expanding applications in functional foods and fortified products, and aggressive investment in fermentation-based sustainable production methods yielding high-purity, non-allergenic vegan variants are further supporting demand across the forecast period.

Restraints: Shellfish allergen concerns and raw material sourcing constraints limiting market expansion

One of the main barriers to market growth is the shellfish-derived nature of the majority of current glucosamine production, which excludes shellfish-allergic consumers and creates supply chain dependency on crustacean shell byproduct availability that can introduce sourcing constraints and price volatility.

Moreover, the increase in the production cost of fermentation process-produced and non-shrimp glucosamine products remains an important barrier to the widespread use of such products due to the rise in the popularity of vegan and hypoallergenic products. The differences in regulation of supplement claims and glucosamine classification in various countries represent another obstacle for producers operating internationally.

Opportunities: Expansion of fermentation-based production and functional food integration creating new growth avenues

Digitization and personalization of health care products will create a new competitive environment where higher value-added and differentiated products will be created due to greater investments being made by manufacturers in fermentation technology to produce glucosamine that is high purity and vegan friendly without allergies.

There is a considerable growth opportunity in the continued expansion of glucosamine integration into functional foods and fortified products beyond traditional standalone supplement formats. The expansion of dietary supplement retail infrastructure and aging population growth in emerging markets across Asia Pacific and Latin America is likely to unlock substantial new demand throughout the forecast period.

Recent Developments:

• 2025: Rousselot announced a multimillion-dollar investment in its fermentation-based glucosamine production facilities in Europe, aiming to increase capacity and reduce environmental footprint while appealing to environmentally conscious consumers.
• 2025: Cargill expanded its glucosamine production capacity, strengthening its ability to supply nutraceutical and dietary supplement manufacturers with reliable, high-quality glucosamine ingredients.
• 2026: NOW Health Group launched an updated N-acetyl glucosamine dietary supplement line, targeting consumers seeking joint health support alongside skin and digestive health benefits.
• 2026: Golden Shell Pharmaceutical expanded its glucosamine sulfate manufacturing capacity, strengthening its position supplying pharmaceutical-grade glucosamine to clinical and dietary supplement customers globally.

Glucosamine Market key players are:

• Cargill, Incorporated
• Rousselot (Darling Ingredients Inc.)
• Glanbia plc
• Zhejiang Aoxing Biotechnology Co., Ltd.
• Golden Shell Pharmaceutical Co., Ltd.
• Blackmores Ltd.
• Koyo Chemical Co., Ltd.
• Panvo Organics Pvt. Ltd.
• T.C. Union Group Ltd.
• Foodchem International Corporation
• Ethical Naturals Inc.
• Schiff Nutrition International, Inc.
• Health World Ltd.
• NOW Health Group, Inc.
• Bio-gen Extracts Private Limited
• Pharma Base S.A.
• CAPTEK Softgel International Inc.
• TSI Health Sciences, Inc.
• CellMark Chemicals
• Zhejiang Zhoushan Putuo Xinxing Pharmas Co., Ltd.

Glucosamine Market Report Scope :